RESUMO
Basal-like breast cancers (BBC) exhibit subtype-specific phenotypic and transcriptional responses to stroma, but little research has addressed how stromal-epithelial interactions evolve during early BBC carcinogenesis. It is also unclear how common genetic defects, such as p53 mutations, modify these stromal-epithelial interactions. To address these knowledge gaps, we leveraged the MCF10 progression series of breast cell lines (MCF10A, MCF10AT1, and MCF10DCIS) to develop a longitudinal, tissue-contextualized model of p53-deficient, pre-malignant breast. Acinus asphericity, a morphogenetic correlate of cell invasive potential, was quantified with optical coherence tomography imaging, and gene expression microarrays were performed to identify transcriptional changes associated with p53 depletion and stromal context. Co-culture with stromal fibroblasts significantly increased the asphericity of acini derived from all three p53-deficient, but not p53-sufficient, cell lines, and was associated with the upregulation of 38 genes. When considered as a multigene score, these genes were upregulated in co-culture models of invasive BBC with increasing stromal content, as well as in basal-like relative to luminal breast cancers in two large human datasets. Taken together, stromal-epithelial interactions during early BBC carcinogenesis are dependent upon epithelial p53 status, and may play important roles in the acquisition of an invasive morphologic phenotype.
Assuntos
Neoplasias da Mama/patologia , Transformação Celular Neoplásica/patologia , Proteína Supressora de Tumor p53/deficiência , Linhagem Celular Tumoral , Técnicas de Cocultura , Células Epiteliais/patologia , Feminino , Fibroblastos , Perfilação da Expressão Gênica , Técnicas de Silenciamento de Genes , Humanos , Invasividade Neoplásica/patologia , Células Estromais/patologia , Proteína Supressora de Tumor p53/genéticaRESUMO
Adequate antiretroviral (ARV) concentrations in lymphoid tissues are critical for optimal antiretroviral therapy (ART). While the spleen contains 25% of the body's lymphocytes, there are minimal data on ARV penetration in this organ. This study quantified total and protein-unbound splenic ARV concentrations and determined whether drug transporters, sex, or infection status were modifiers of these concentrations in animal models and humans. Two humanized mice models (hu-HSC-Rag [n = 36; 18 HIV-positive (HIV+) and 18 HIV-negative (HIV-)] and bone marrow-liver-thymus [n = 13; 7 HIV+ and 6 HIV-]) and one nonhuman primate (NHP) model (rhesus macaque [n = 18; 10 SHIV+ and 8 SHIV-]) were dosed to steady state with ARV combinations. HIV+ human spleens (n = 14) from the National NeuroAIDS Tissue Consortium were analyzed postmortem (up to 24 h postdose). ARV concentrations were measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS), drug transporter concentrations were measured with LC-MS proteomics, and protein binding in NHP spleens was determined by rapid equilibrium dialysis. Mice generally had the lowest splenic concentrations of the three species. Protein binding in splenic tissue was 6 to 96%, compared to 76 to 99% in blood plasma. NHPs had quantifiable Mrp4, Bcrp, and Ent1 concentrations, and humans had quantifiable ENT1 concentrations. None significantly correlated with tissue ARV concentrations. There was also no observable influence of infection status or sex. With these dosing strategies, NHP splenic penetration most closely resembled that of humans. These data can inform tissue pharmacokinetic scaling to humans to target HIV reservoirs by identifying important species-related differences.
Assuntos
Fármacos Anti-HIV , Infecções por HIV , Preparações Farmacêuticas , Membro 2 da Subfamília G de Transportadores de Cassetes de Ligação de ATP , Animais , Fármacos Anti-HIV/uso terapêutico , Cromatografia Líquida , Infecções por HIV/tratamento farmacológico , Humanos , Macaca mulatta , Camundongos , Modelos Animais , Proteínas de Neoplasias , Baço , Espectrometria de Massas em TandemRESUMO
For HIV cure strategies like "kick and kill" to succeed, antiretroviral (ARV) drugs must reach effective concentrations in putative viral reservoirs. We characterize penetration of six ARVs in three preclinical animal models and humans. We found that standard dosing strategies in preclinical species closely mimicked tissue concentrations in humans for some, but not all, ARVs. These results have implications for interpreting HIV treatment, prevention, or cure interventions between preclinical and clinical models.
Assuntos
Antirretrovirais/uso terapêutico , Infecções por HIV/tratamento farmacológico , Animais , Fármacos Anti-HIV/uso terapêutico , Sulfato de Atazanavir/uso terapêutico , Emtricitabina/uso terapêutico , Feminino , Humanos , Técnicas In Vitro , Maraviroc/uso terapêutico , Camundongos , Raltegravir Potássico/uso terapêutico , Tenofovir/uso terapêuticoRESUMO
While highly active antiretroviral therapy (HAART) has significantly reduced mortality rates in patients with human immunodeficiency virus type 1 (HIV-1), its efficacy may be impeded by emergence of drug resistance caused by lack of patient adherence. A therapeutic strategy that requires infrequent drug administration as a result of sustained release of antiretroviral drugs would put less burden on the patient. Long-acting antiretroviral prodrugs for HIV therapy were synthesized through modification of the active drugs, emtricitabine (FTC) and elvitegravir (EVG), with docosahexaenoic acid (DHA) in one-step, one-pot, high-yielding reactions. The in vitro drug release profiles of these synthetic conjugates demonstrated sustained and controlled release of the active drug over a period of 3-4â¯weeks attributable to the hydrolysis of the chemical linker in conjunction with the hydrophilicity of the parent drug. Both conjugates exhibited superior antiviral activities in tissue culture models of HIV replication as compared to those of the free drugs, strengthening their role as potent prodrugs for HIV therapy. Pharmacokinetic analysis in CD1 mice further confirmed the long-acting aspect of these conjugates with released drug concentrations in plasma detected at their respective IC90/IC95 values over a period of 2â¯weeks and discernable amounts of active drug even at 6â¯weeks. Our findings suggest that the injectable small molecule conjugates could be used as long-acting controlled release of FTC and EVG in attempts to mitigate adherence-related HIV resistance.
Assuntos
Fármacos Anti-HIV/administração & dosagem , Ácidos Docosa-Hexaenoicos/administração & dosagem , Emtricitabina/administração & dosagem , Pró-Fármacos/administração & dosagem , Quinolonas/administração & dosagem , Animais , Fármacos Anti-HIV/química , Fármacos Anti-HIV/farmacocinética , Linhagem Celular , Preparações de Ação Retardada/administração & dosagem , Preparações de Ação Retardada/química , Preparações de Ação Retardada/farmacocinética , Ácidos Docosa-Hexaenoicos/química , Ácidos Docosa-Hexaenoicos/farmacocinética , Liberação Controlada de Fármacos , Emtricitabina/química , Emtricitabina/farmacocinética , Feminino , Infecções por HIV/tratamento farmacológico , Humanos , Injeções Intramusculares , Camundongos , Pró-Fármacos/química , Pró-Fármacos/farmacocinética , Quinolonas/química , Quinolonas/farmacocinéticaRESUMO
The hippocampus supports a cognitive map of space and is critical for encoding declarative memory (who, what, when and where). Recent studies have implicated hippocampal subfield CA2 in social and contextual memory but how it does so remains unknown. Here we find that in adult male rats, presentation of a social stimulus (novel or familiar rat) or a novel object induces global remapping of place fields in CA2 with no effect on neuronal firing rate or immediate early gene expression. This remapping did not occur in CA1, suggesting this effect is specific for CA2. Thus, modification of existing spatial representations might be a potential mechanism by which CA2 encodes social and novel contextual information.
Assuntos
Região CA2 Hipocampal/fisiologia , Habilidades Sociais , Animais , Comportamento Animal , Masculino , Memória , Neurônios/fisiologia , Ratos , Ratos Sprague-Dawley , Percepção EspacialRESUMO
BACKGROUND: Modern toxicology is shifting from an observational to a mechanistic science. As part of this shift, high-throughput toxicity assays are being developed using alternative, nonmammalian species to prioritize chemicals and develop prediction models of human toxicity. METHODS: The nematode Caenorhabditis elegans (C. elegans) was used to screen the U.S. Environmental Protection Agency's (EPA's) ToxCast™ Phase I and Phase II libraries, which contain 292 and 676 chemicals, respectively, for chemicals leading to decreased larval development and growth. Chemical toxicity was evaluated using three parameters: a biologically defined effect size threshold, half-maximal activity concentration (AC50), and lowest effective concentration (LEC). RESULTS: Across both the Phase I and Phase II libraries, 62% of the chemicals were classified as active ≤ 200 µM in the C. elegans assay. Chemical activities and potencies in C. elegans were compared with those from two zebrafish embryonic development toxicity studies and developmental toxicity data for rats and rabbits. Concordance of chemical activity was higher between C. elegans and one zebrafish assay across Phase I chemicals (79%) than with a second zebrafish assay (59%). Using C. elegans or zebrafish to predict rat or rabbit developmental toxicity resulted in balanced accuracies (the average value of the sensitivity and specificity for an assay) ranging from 45% to 53%, slightly lower than the concordance between rat and rabbit (58%). CONCLUSIONS: Here, we present an assay that quantitatively and reliably describes the effects of chemical toxicants on C. elegans growth and development. We found significant overlap in the activity of chemicals in the ToxCast™ libraries between C. elegans and zebrafish developmental screens. Incorporating C. elegans toxicological assays as part of a battery of in vitro and in vivo assays provides additional information for the development of models to predict a chemical's potential toxicity to humans. CITATION: Boyd WA, Smith MV, Co CA, Pirone JR, Rice JR, Shockley KR, Freedman JH. 2016. Developmental effects of the ToxCast™ Phase I and II chemicals in Caenorhabditis elegans and corresponding responses in zebrafish, rats, and rabbits. Environ Health Perspect 124:586-593; http://dx.doi.org/10.1289/ehp.1409645.
Assuntos
Caenorhabditis elegans/efeitos dos fármacos , Poluentes Ambientais/toxicidade , Testes de Toxicidade/métodos , Animais , Caenorhabditis elegans/crescimento & desenvolvimento , Ensaios de Triagem em Larga Escala , Coelhos , Ratos , Peixe-ZebraRESUMO
INTRODUCTION: Increased animal fat consumption is associated with increased premenopausal breast cancer risk in normal weight, but not overweight, women. This agrees with our previous findings in obesity-resistant BALB/c mice, in which exposure to a high saturated animal fat diet (HFD) from peripuberty through adulthood promoted mammary tumorigenesis. Epidemiologic and animal studies support the importance of puberty as a life stage when diet and environmental exposures affect adult breast cancer risk. In this study, we identified the effects of peripubertal exposure to HFD and investigated its mechanism of enhancing tumorigenesis. METHODS: Three-week-old BALB/c mice fed a low-fat diet (LFD) or HFD were subjected to 7,12-dimethylbenz[a]anthracene (DMBA)-induced carcinogenesis. At 9 weeks of age, half the mice on LFD were switched to HFD (LFD-HFD group) and half the mice on HFD were switched to LFD (HFD-LFD group). Tumor gene expression was evaluated in association with diet and tumor latency. RESULTS: The peripubertal HFD reduced the latency of DMBA-induced mammary tumors and was associated with tumor characteristics similar to those in mice fed a continuous HFD. Notably, short-latency tumors in both groups shared gene expression characteristics and were more likely to have adenosquamous histology. Both HFD-LFD and continuous HFD tumors showed similar gene expression patterns and early latency. Adult switch from HFD to LFD did not reverse peripubertal HFD tumor promotion. Increased proliferation, hyperplasia, and macrophages were present in mammary glands before tumor development, implicating these as possible effectors of tumor promotion. Despite a significant interaction between pubertal diet and carcinogens in tumor promotion, peripubertal HFD by itself produced persistent macrophage recruitment to mammary glands. CONCLUSIONS: In obesity-resistant mice, peripubertal HFD is sufficient to irreversibly promote carcinogen-induced tumorigenesis. Increased macrophage recruitment is likely a contributing factor. These results underscore the importance of early life exposures to increased adult cancer risk and are consistent with findings that an HFD in normal weight premenopausal women leads to increased breast cancer risk. Notably, short-latency tumors occurring after peripubertal HFD had characteristics similar to human basal-like breast cancers that predominantly develop in younger women.
Assuntos
Carcinogênese/metabolismo , Carcinoma Adenoescamoso/etiologia , Dieta Hiperlipídica/efeitos adversos , Neoplasias Mamárias Experimentais/etiologia , Animais , Carcinoma Adenoescamoso/metabolismo , Quimiocinas/metabolismo , Feminino , Glândulas Mamárias Animais/crescimento & desenvolvimento , Glândulas Mamárias Animais/metabolismo , Glândulas Mamárias Animais/patologia , Neoplasias Mamárias Experimentais/metabolismo , Camundongos Endogâmicos BALB C , Maturidade Sexual , Transcriptoma , beta Catenina/metabolismoRESUMO
An open-source implementation of a previously published integrated testing strategy (ITS) for skin sensitization using a Bayesian network has been developed using R, a free and open-source statistical computing language. The ITS model provides probabilistic predictions of skin sensitization potency based on in silico and in vitro information as well as skin penetration characteristics from a published bioavailability model (Kasting et al., 2008). The structure of the Bayesian network was designed to be consistent with the adverse outcome pathway published by the OECD (Jaworska et al., 2011, 2013). In this paper, the previously published data set (Jaworska et al., 2013) is improved by two data corrections and a modified application of the Kasting model. The new data set implemented in the original commercial software package and the new R version produced consistent results. The data and a fully documented version of the code are publicly available (http://ntp.niehs.nih.gov/go/its).
Assuntos
Alternativas aos Testes com Animais , Teorema de Bayes , Testes Cutâneos , Software , Testes de Toxicidade/métodos , Animais , Simulação por Computador , Interpretação Estatística de Dados , Dermatite de Contato , Técnicas In Vitro , PropriedadeRESUMO
BACKGROUND: Age is the strongest breast cancer risk factor, with overall breast cancer risk increasing steadily beginning at approximately 30 years of age. However, while breast cancer risk is lower among younger women, young women's breast cancer may be more aggressive. Although, several genomic and epidemiologic studies have shown higher prevalence of aggressive, estrogen-receptor negative breast cancer in younger women, the age-related gene expression that predisposes to these tumors is poorly understood. Characterizing age-related patterns of gene expression in normal breast tissues may provide insights on etiology of distinct breast cancer subtypes that arise from these tissues. METHODS: To identify age-related changes in normal breast tissue, 96 tissue specimens from patients with reduction mammoplasty, ages 14 to 70 years, were assayed by gene expression microarray. RESULTS: Significant associations between gene expression levels and age were identified for 802 probes (481 increased, 321 decreased with increasing age). Enriched functions included "aging of cells," "shape change," and "chemotaxis," and enriched pathways included Wnt/beta-catenin signaling, Ephrin receptor signaling, and JAK/Stat signaling. Applying the age-associated genes to publicly available tumor datasets, the age-associated pathways defined two groups of tumors with distinct survival. CONCLUSION: The hazard rates of young-like tumors mirrored that of high-grade tumors in the Surveillance, Epidemiology, and End Results Program, providing a biologic link between normal aging and age-related tumor aggressiveness. IMPACT: These data show that studies of normal tissue gene expression can yield important insights about the pathways and biologic pressures that are relevant during tumor etiology and progression.
Assuntos
Envelhecimento/metabolismo , Neoplasias da Mama/etiologia , Mama/metabolismo , Regulação Neoplásica da Expressão Gênica , Adolescente , Adulto , Fatores Etários , Idoso , Neoplasias da Mama/metabolismo , Feminino , Expressão Gênica , Humanos , Incidência , Mamoplastia , Pessoa de Meia-Idade , Transdução de SinaisRESUMO
INTRODUCTION: A gene expression signature indicative of activated wound responses is common to more than 90% of non-neoplastic tissues adjacent to breast cancer, but these tissues also exhibit substantial heterogeneity. We hypothesized that gene expression subtypes of breast cancer microenvironment can be defined and that these microenvironment subtypes have clinical relevance. METHODS: Gene expression was evaluated in 72 patient-derived breast tissue samples adjacent to invasive breast cancer or ductal carcinoma in situ. Unsupervised clustering identified two distinct gene expression subgroups that differed in expression of genes involved in activation of fibrosis, cellular movement, cell adhesion and cell-cell contact. We evaluated the prognostic relevance of extratumoral subtype (comparing the Active group, defined by high expression of fibrosis and cellular movement genes, to the Inactive group, defined by high expression of claudins and other cellular adhesion and cell-cell contact genes) using clinical data. To establish the biological characteristics of these subtypes, gene expression profiles were compared against published and novel tumor and tumor stroma-derived signatures (Twist-related protein 1 (TWIST1) overexpression, transforming growth factor beta (TGF-ß)-induced fibroblast activation, breast fibrosis, claudin-low tumor subtype and estrogen response). Histological and immunohistochemical analyses of tissues representing each microenvironment subtype were performed to evaluate protein expression and compositional differences between microenvironment subtypes. RESULTS: Extratumoral Active versus Inactive subtypes were not significantly associated with overall survival among all patients (hazard ratio (HR) = 1.4, 95% CI 0.6 to 2.8, P = 0.337), but there was a strong association with overall survival among estrogen receptor (ER) positive patients (HR = 2.5, 95% CI 0.9 to 6.7, P = 0.062) and hormone-treated patients (HR = 2.6, 95% CI 1.0 to 7.0, P = 0.045). The Active subtype of breast microenvironment is correlated with TWIST-overexpression signatures and shares features of claudin-low breast cancers. The Active subtype was also associated with expression of TGF-ß induced fibroblast activation signatures, but there was no significant association between Active/Inactive microenvironment and desmoid type fibrosis or estrogen response gene expression signatures. Consistent with the RNA expression profiles, Active cancer-adjacent tissues exhibited higher density of TWIST nuclear staining, predominantly in epithelium, and no evidence of increased fibrosis. CONCLUSIONS: These results document the presence of two distinct subtypes of microenvironment, with Active versus Inactive cancer-adjacent extratumoral microenvironment influencing the aggressiveness and outcome of ER-positive human breast cancers.
Assuntos
Neoplasias da Mama/genética , Neoplasias da Mama/mortalidade , Carcinoma Intraductal não Infiltrante/genética , Regulação Neoplásica da Expressão Gênica , Microambiente Tumoral/genética , Neoplasias da Mama/patologia , Carcinoma Intraductal não Infiltrante/mortalidade , Carcinoma Intraductal não Infiltrante/patologia , Claudinas/genética , Feminino , Fibroblastos/patologia , Fibrose/genética , Humanos , Estimativa de Kaplan-Meier , Proteínas Nucleares/genética , Proteínas Nucleares/metabolismo , Receptores de Estrogênio/genética , Receptores de Estrogênio/metabolismo , Fator de Crescimento Transformador beta/genética , Fator de Crescimento Transformador beta/metabolismo , Proteína 1 Relacionada a Twist/genética , Proteína 1 Relacionada a Twist/metabolismoRESUMO
PURPOSE: Cancer progression is mediated by processes that are also important in wound repair. As a result, cancers have been conceptualized as overhealing wounds or "wounds that do not heal," and gene expression signatures reflective of wound repair have shown value as predictors of breast cancer survival. Despite the widespread acknowledgment of commonalities between host responses to wounds and host responses to cancer, the gene expression responses of normal tissue adjacent to cancers have not been well characterized. EXPERIMENTAL DESIGN: Using RNA extracted from histologically normal breast tissue from 107 patients, including 60 reduction mammoplasty patients and 47 cancer patients, we measured whole genome expression profiles and identified a gene expression signature that is induced in response to breast cancer. RESULTS: This signature represents an in vivo "wound response" signature that is differentially expressed in the normal tissue of breast cancer patients compared with those without disease and is highly accurate (at least 92% sensitivity and 98% specificity) in distinguishing diseased and nondiseased. The in vivo wound response signature is highly prognostic of breast cancer survival, and there is a strong association between the groups identified by this signature and those identified using serum-treated fibroblasts and other microenvironment-derived or microenvironment-related signatures. CONCLUSIONS: The prevalence of the wound response signature in histologically normal tissue adjacent to breast cancer suggests that microenvironment response is an important variable in breast cancer progression and may be an important target for clinical interventions.
Assuntos
Neoplasias da Mama/metabolismo , Neoplasias da Mama/patologia , Mama/patologia , Mama/cirurgia , Neoplasias da Mama/cirurgia , Ciclo-Oxigenase 2/metabolismo , Proteína Rica em Cisteína 61/metabolismo , Progressão da Doença , Feminino , Perfilação da Expressão Gênica , Regulação Neoplásica da Expressão Gênica , Genoma Humano , Humanos , Imuno-Histoquímica/métodos , Mamoplastia , Neovascularização Patológica , Reprodutibilidade dos Testes , CicatrizaçãoRESUMO
OBJECTIVE: Patients requiring prolonged acute mechanical ventilation (PAMV, defined as mechanical ventilation > or = 96 hrs) have hospital survival rates similar to those requiring < 96 hrs of mechanical ventilation and consume about two thirds of hospital resources devoted to mechanical ventilation care. Because of this disproportionate resource utilization and the shifting U.S. demographics, we projected the expected volume of adult PAMV cases through year 2020. DESIGN: We used data from the National Inpatient Sample/Health Care Utilization Project of the Agency for Healthcare Research and Quality from 2000 to 2005 to calculate historic annual age-adjusted PAMV incidence rates using estimated population statistics from the U.S. Census Bureau. To predict future growth by age group, we fit linear regression models to the historic incidence rate changes. Age-adjusted estimates were computed using population projections obtained from the U.S. Census Bureau. SETTING: U.S. hospitals. PATIENTS: Nationally representative sample of U.S. hospital discharges with PAMV (code 96.72 from the International Classification of Diseases, Ninth Revision). INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Historic annualized increase in PAMV was approximately 5.5%, compared with approximately 1% per annum growth in both U.S. population and hospital admissions. The fastest annualized growth was observed among 44-65 (7.9%) followed by 18-44 (4.7%), > or = 85 (4.6%), and 65-84 (3.4%) age groups. Factoring in both age-specific growth in PAMV population and overall U.S. adult population changes, we project PAMV to more than double from approximately 250,000 cases in 2000 to 605,898 cases by year 2020. CONCLUSIONS: Patients undergoing PAMV are a large and resource-intensive population whose increase outpaces growth in the general U.S. population and in overall hospital volume. Policy makers must factor this projected rapid growth in frequency of PAMV into future resource and work force planning. Given the resource-intensive nature of these patients, strategies need to be developed to optimize their care and to increase efficiency of healthcare delivery to this large and growing population.
Assuntos
Respiração Artificial/estatística & dados numéricos , Adolescente , Adulto , Fatores Etários , Idoso , Idoso de 80 Anos ou mais , Atenção à Saúde/estatística & dados numéricos , Humanos , Pessoa de Meia-Idade , Fatores de TempoRESUMO
Inducible genes are expressed in the presence of an external stimulus. Individual cells may exhibit either a binary or graded response to such signals. It has been hypothesized that the chemical kinetics of transcription factor/DNA interactions can account for both these scenarios (EMBO J. 9(9) (1990) 2835; BioEssays 14(5) (1992) 341). To explore this question, we have conducted work based on the experimental results of Fiering et al. (Genes Dev. 4 (10) (1990) 1823). In these experiments, three upstream NF-AT binding sites control transcription of the lacZ gene, which codes for the enzyme beta-Galactosidase. The experimental data show a binary response for this system. We consider the effects of fluctuations in NF-AT binding on the response of the system. Our modeling results are in good qualitative agreement with the experimental data, and illustrate how the binary and graded responses can stem from the same underlying mechanism.
Assuntos
Células/metabolismo , Regulação da Expressão Gênica , Proteínas Nucleares , Transdução de Sinais/fisiologia , Fatores de Transcrição/metabolismo , Animais , Proteínas de Ligação a DNA/metabolismo , Interleucina-2/genética , Modelos Biológicos , Fatores de Transcrição NFATC , Ligação Proteica , Transcrição Gênica , beta-Galactosidase/genéticaRESUMO
The purpose of this study was to assess cutaneous enzyme activity in response to topical exposure to jet fuel, using enzyme histochemistry to analyze alkaline phosphatase (ALP), acid phosphatase (ACP), and nonspecific esterase (NSE) in the skin of pigs. Yorkshire pigs were exposed to Jet-A, JP-8, and JP-8(100) fuels for 5 h, 24 h, and 5 days under occluded Hill Top chambers (25 muL), nonoccluded conditions (25 muL), and occluded fabric conditions (335 muL). For ALP, the fabric Jet-A, JP-8, and JP-8(100) were significantly more intense (p < .05) than control sites in the stratum basale layer. ACP staining showed a general increase between 24 h and 5 days in most layers in the Hill Top chamber experiment, but no treatment effects. The sites of nonoccluded fabric involving JP-8 and JP-8(100) demonstrated significantly more staining (p < .05) of NSE than at control sites at 24 h in both the stratum spinosum and stratum basale layers. In addition, NSE staining at 5 days at the site where the fabric was dosed with JP-8 and JP-8(100) was significantly greater (p < .05) than in the occluded-fabric control site in the stratum granulosum layer. The increased distribution and significant difference in staining by these enzymes in jet fuel-treated skin across many layers (particularly ALP) strongly supports the conclusion that enzyme histochemistry can be used effectively as an early biomarker of cellular injury.